
About
Synvia develops integrated services and digital platforms for the pharmaceutical and life sciences industries, with work spanning clinical research, bioequivalence, pharmaceutical equivalence, laboratory analyses, toxicology, and clinical-operation software. It serves pharmaceutical companies in Brazil and internationally, with activities centered in Brazil.
Synvia is a CRDMO in São Paulo, Brazil. It lists 17 services, including Clinical research (Phases I to IV), BE and Phase I studies (PK/PD) and Pharmaceutical equivalence.
Services
Clinical research (Phases I to IV)
Conducts clinical research studies across Phases I to IV.
BE and Phase I studies (PK/PD)
Runs bioequivalence studies and Phase I pharmacokinetic/pharmacodynamic studies.
Pharmaceutical equivalence
Provides pharmaceutical equivalence services for medicines development and registration.
CRO services
Offers contract research organization services for pharmaceutical development and regulatory support.
Analytical services
Performs analytical services for development, registration, and quality control using LC-MS/MS, chromatographic, and physicochemical techniques.
Development and validation of analytical methods
Creates and validates analytical methods for pharmaceutical analyses.
Development of dissolution methods
Develops dissolution methods for different release profiles and dosage forms.
Shake-flask solubility study
Performs shake-flask solubility studies under controlled conditions across relevant media and pH ranges.
9 more services
- Forced degradation study
- Extractables and leachables (E&L)
- Elemental impurities
- Nitrosamine study
- Process and cleaning validation (analytical stage)
- Quality control services – REBLAS
- Synvia TrialCore
- Toxicology
- Diagnostics
How to order from Synvia
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- LC-MS/MS
- PK/PD
- Toxicology
- Shake-flask solubility
- Scale and capacity
- +35 LC-MS/MS
- +900 employees
- +2.000 studies
- +200 pharmaceutical industries
- 25.000/day processing capacity in toxicology
- Serves more than 1.000 cities
- Therapeutic areas
- Oncology
- Immunology
- Psychiatry
- Neurology
- Gynecology
- Ophthalmology
9 more
- Infectious diseases
- Cardiology
- Endocrinology
- Dermatology
- Orthopedics
- Rheumatology
- Pediatrics
- Coloproctology
- Urology
Instruments and platforms
- LC-MS/MS
- GC-MS/MS
- ICP-MS
- eCRF
- CTMS
- eTMF
- ePRO
Modalities and species
- Modalities
- Canabidiol
Details
- Type
- CRDMO
- Team
- +900 colaboradores
- Quality
- ANVISA · EMA · FDA · RDC nº 166/2017 · RDC nº 31/2010 · Guia nº 14/2021 · RDC nº 964/2025 · Guia nº 79/2025 · ICH Q3E · ICH Q3D · RDC nº 677/2022 · Guia nº 50/2021 · RDC nº 658/2022 · IN nº 138/2022 · RDC nº 928 de 25/09/2024 · RDC 512 de 2021
- Based in
- São Paulo, Brazil
- Serves
- Brazil, world